Procurement Summary
Country : USA
Summary : Fenway-Lateral Flow Assay Evaluations
Deadline : 16 Jul 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 103943967
Document Ref. No. : 000HCKBG-2024-86298
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
NOTICE OF INTENT TO ISSUE AN ORDER. This is not a request for competitive proposals/quotes. The Centers for Disease Control and Prevention (CDC) hereby announces its intent to issue a sole source order to Fenway Institute for ntegrase Inhibitor-based Antiretroviral Therapy or Long-acting Pre-Exposure Prophylaxis (PrEP).
The NAICS code for this acquisition is 541715.
A determination by the Government not to compete this proposed action will be based on responses to this notice and is solely in the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
All vendors must be registered in the System for Award Management (SAM) at www.sam.gov, prior to an award of a federal contract.
This action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit quotations.
This is not a request for competitive quotations; however, the Government will review any/all product, capabilities, and pricing information submitted prior to the closure of this notice. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
Responsible sources that believe they possess the expertise and capabilities identified above are hereby afforded the opportunity to submit to the Contracting Officer by the due date of this notice, their written capabilities statement and pricing information in the format they choose, not to exceed 10 pages. Please forward, as applicable, any capabilities, product, pricing informatio...
Active Contract Opportunity Notice ID 000HCKBG-2024-86298 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier CENTERS FOR DISEASE CONTROL AND PREVENTION Office CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jul 08, 2024 08:14 am EDT
Original Date Offers Due: Jul 16, 2024 02:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Jul 31, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: AN22 - HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; APPLIED RESEARCH
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Place of Performance: Atlanta, GA USA
Documents
Tender Notice
A13_SSJ_CO-Signed.pdf